Curamir Therapeutics

Curamir Therapeutics is dedicated to developing cancer therapies based on micro RNA (miRNA). Leveraging its proprietary miRNA engineering platform and insights into cancer biology, the company develops innovative treatments aimed at addressing unmet needs to overcome resistance and toxicity associated with current oncology therapies.